Resources

  • References


    Acidophilus and other probiotics. EBSCO Natural and Alternative Treatments website. Available at:
    http://www.ebscohost.com/healthLibrary/. Updated June 2008. Accessed July 15, 2008.


    Conn HF, Rakel RE.
    Conn's Current Therapy. Philadelphia, PA: WB Saunders Co; 2001.


    Drossman DA.
    Treatment for bacterial overgrowth in the irritable bowel syndrome.
    Ann Intern Med. 2006;145:626-628.


    Griffith HW.
    Griffith's 5-Minute Clinical Consult. Baltimore, MD: Lippincott Williams Wilkins; 1999.


    Halvorson HA, Schlett CD, et al.
    Postinfectious irritable bowel syndrome—a meta-analysis.
    Am J Gastroenterol. 2006;101:1894-1899.


    Irritable bowel syndrome.
    American Society of Colon and Rectal Surgeons website. Available at:
    http://www.fascrs.org/.
    Update October 2007. Accessed July 15, 2008.


    Irritable bowel syndrome. EBSCO DynaMed website. Available at:
    https://dynamed.ebscohost.com/about/about-us. Updated December 2008. Accessed January 6, 2009.


    Irritable bowel syndrome (IBS). EBSCO Health Library website. Available at:
    http://www.ebscohost.com/healthLibrary/. Updated July 2008. Accessed July 7, 2008.


    Irritable bowel syndrome.
    National Institute of Diabetes and Digestive and Kidney Diseases website. Available at:
    http://www.niddk.nih.gov/.
    Update September 2007. Accessed July 15, 2008.


    Murch S. Allergy and intestinal dysmotility—evidence of genuine causal linkage?
    Curr Opin Gastroenterol. 2006;22:664-668.


    Rubin G, De Wit N, et al.
    The diagnosis of IBS in primary care: consensus development using nominal group technique.
    Family Practitioner. 2006;23:687-692.


    Sleisenger MH, Fordtran JS, et al.
    Sleisenger Fordtran's Gastrointestinal and Liver Disease. 6th ed. Philadelphia, PA: WB Saunders Co; 1998.


    Talley NJ, Boyce PM, et al. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study.
    Gut.1998;42: 47-53.


    Yan F, Polk DB. Probiotics as functional food in the treatment of diarrhea.
    Current Opinion in Clinical Nutrition and Metabolic Care
    . 2006;9:717-721.


    9/26/2006 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: Mueller-Lissner S, Tytgat GN, et al. Placebo-and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain.
    Alimentary Pharmacology and Therapeutics. 2006;23:1741-1748.


    4/10/2007 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: US Food and Drug Administration. FDA announces discontinued marketing of GI drug, Zelnorm, for safety reasons [press release]. March 30, 2007. US Food and Drug Administration website. Available at:
    http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108879.htm.


    1/6/2009 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: Ford AC, Talley NJ, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.
    BMJ
    .
    2008;337:a2313.


    10/9/2009 DynaMed Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: Lee S, Wu J, et al. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study.
    Aliment Pharmacol Ther.
    2009;30(6):643.


    11/4/2009 DynaMed Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: Ford AC, Brandt LJ, et al. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis.
    Am J Gastroenterol.
    2009;104(7):1831-1843.


    1/11/2010 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: Wittmann T, Paradowski L, et al. Clinical trial: efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome: results of a randomized, double-blind, placebo-controlled study.
    Aliment Pharmacol Ther.
    2009 Dec 10. [Epub ahead of print]


    7/16/2010 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us
    : Dorn SD. Systematic review: self-management support interventions for irritable bowel syndrome.
    Aliment Pharmacol Ther.
    2010 May 22. [Epub ahead of print]


    1/14/2011 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: Pimentel M, Lembo A, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation.
    N Engl J Med.
    2011;364(1):22-32.


    4/22/2011 DynaMed's Systematic Literature Surveillance
    https://dynamed.ebscohost.com/about/about-us: Johannesson E, Simrén M, et al.
    Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial.
    Am J Gastroenterol.
    2011 Jan 4. [Epub ahead of print]

  • Resources

    American College of Gastroenterology

    http://gi.org

    American Gastroenterological Association

    http://www.gastro.org

    Irritable Bowel Syndrome Association

    http://www.ibsgroup.org

  • Canadian Resources

    Canadian Digestive Health Foundation

    http://www.cdhf.ca